The nation of Zimbabwe has turned down a major US health deal valued at $367m (272 million pounds) spanning five years over the United States' demand for sensitive information.
This rejection was revealed following a government memo dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".
A government spokesman later stated that the United States was requesting health data for scientific study and commercial purposes but was unwilling to share the benefits from any future vaccines.
"We must now begin the challenging and unfortunate task of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for more dialogue to find a agreement acceptable to both sides so the country's vital HIV programme can continue.
Wider Context
Zimbabwe's decision comes after a comparable case in Kenya, where a court halted a related deal with the US following legal challenges were raised about the security of Kenyans' medical information.
After resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his government was seeking government-to-government deals to enhance openness and responsibility.
Based on statements, Sixteen African countries have so far signed these new agreements, constituting more than $18.3bn of fresh investment.
Details of the Rejected Deal
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership could have provided immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"The proposal required Zimbabwe to share its biological resources and data over an extended period, with no equivalent guarantee of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that provided information," Mangwana explained.
"Put simply, our country would provide the raw materials for medical research with no certainty that the end products would be available to our citizens if a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining systems previously established through the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage future pandemics.
"This framework is intended to ensure that when a country contributes its information, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome further dialogue with our US partners on how future co-operation might be designed in a manner that respects the sovereignty and interests of both nations."
Medical Community Reaction
A leading public health body stated it understood the government's concerns, but urged that talks must proceed given that much of the nation's Aids initiatives relied on external financing.
"If technical issues exist, including those involving data governance or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," the group said.
The situation highlights the ongoing tensions between accepting vital foreign assistance and protecting local interests in an ever more interconnected world.